Skip to main content

U.S. Pharmaceutical Sales - Q3 2013

The following is a list of the top 100 prescribed medicines by US National Sales in Q3 2013. Figures include sales through both retail and hospital channels, listed by drug name and units sold in the United States.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q3 2013 by Units Sold

Rank Drug Units (000)
1 (1) acetaminophen/hydrocodone
Generic
-5.74% Stats
2 (1) budesonide
Generic
-21.09% Stats
3 (1) ProAir HFA
Teva Pharmaceuticals USA, Inc.
-0.87% Stats
4 (4) OneTouch
7.62% Stats
5 (1) Cymbalta
-7.81% Stats
6 (1) Nexium
AstraZeneca
-10.76% Stats
7 (2) Advair Diskus
GlaxoSmithKline
-7.01% Stats
8 (4) Lantus Solostar
Sanofi
-0.32% Stats
9 (1) Lantus
Sanofi
-14.42% Stats
10 (5) fentanyl
Generic
11.31% Stats
11 (2) enoxaparin
Generic
-10.90% Stats
12 (2) Crestor
AstraZeneca
-11.62% Stats
13 (3) Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc.
-7.14% Stats
14 (3) Levemir
Novo Nordisk
-4.34% Stats
15 (3) NovoLog FlexPen
Novo Nordisk
-2.82% Stats
16 (4) metoprolol
Generic
-0.50% Stats
17 () Fluzone
n/a Stats
18 (3) Humalog
Eli Lilly and Company
-2.19% Stats
19 Novolog
Novo Nordisk
-13.18% Stats
20 (3) Synthroid
AbbVie Inc.
-7.23% Stats
21 (3) Abilify
Otsuka Pharmaceutical Co., Ltd
-5.87% Stats
22 (3) Januvia
Merck
-6.26% Stats
23 (1) Nasonex
Merck
-19.59% Stats
24 (3) Lyrica
Pfizer Inc.
-6.03% Stats
25 (3) Zetia
Merck
-1.81% Stats
26 Symbicort
AstraZeneca
-18.04% Stats
27 (2) Namenda
Allergan plc
-4.14% Stats
28 (2) Diovan
Novartis Pharmaceuticals Corporation
-8.25% Stats
29 (2) Suboxone
-4.15% Stats
30 (5) Remicade
Janssen Pharmaceuticals, Inc.
2.42% Stats
31 (5) fenofibrate
Generic
1.13% Stats
32 (2) AndroGel
AbbVie Inc.
-2.99% Stats
33 (1) Flovent HFA
GlaxoSmithKline
-11.73% Stats
34 (6) Dexilant
Takeda Pharmaceutical Company Limited
-2.22% Stats
35 (3) Restasis
Allergan plc
-4.75% Stats
36 (3) Benicar
Daiichi Sankyo
-5.42% Stats
37 Lovaza
GlaxoSmithKline
-8.81% Stats
38 (5) Lidoderm
Endo Pharmaceuticals Inc.
-18.32% Stats
39 (2) Humalog KwikPen
Eli Lilly and Company
-0.88% Stats
40 (2) OxyContin
Purdue Pharma LP
-3.52% Stats
41 (2) VESIcare
Astellas Pharma US, Inc.
-7.40% Stats
42 (10) Xarelto
21.88% Stats
43 (2) Enbrel
Amgen Inc.
-4.55% Stats
44 (2) Vytorin
Merck
-3.91% Stats
45 (1) Celebrex
Pfizer Inc.
-9.50% Stats
46 () EpiPen 2-Pak
n/a Stats
47 (1) Janumet
Merck
-6.08% Stats
48 (1) Cialis
Eli Lilly and Company
-1.61% Stats
49 () Combivent Respimat
Boehringer Ingelheim Pharmaceuticals, Inc.
n/a Stats
50 (3) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc.
-11.19% Stats
51 (1) Evista
-4.24% Stats
52 (1) doxycycline
Generic
-6.27% Stats
53 (1) methylphenidate
Generic
-7.24% Stats
54 (1) Vyvanse
Takeda Pharmaceutical Company Limited
-5.31% Stats
55 (1) amphetamine/dextroamphetamine
Generic
-5.77% Stats
56 (5) Niaspan
AbbVie Inc.
-18.73% Stats
57 Humira
AbbVie Inc.
-4.91% Stats
58 (1) Epogen
Amgen Inc.
2.30% Stats
59 (1) Victoza
Novo Nordisk
-0.65% Stats
60 Aciphex
Eisai Inc.
-0.34% Stats
61 Rituxan
Genentech, Inc.
-5.78% Stats
62 Truvada
Gilead Sciences, Inc.
-4.12% Stats
63 (1) Avastin
Genentech, Inc.
-4.22% Stats
64 (1) Rebif
EMD Serono, Inc.
-14.07% Stats
65 (2) modafinil
Generic
3.37% Stats
66 (1) Atripla
Gilead Sciences, Inc.
-7.74% Stats
67 (1) Viagra
Pfizer Inc.
-7.59% Stats
68 Seroquel XR
AstraZeneca
-6.72% Stats
69 (1) Renvela
Sanofi
-0.30% Stats
70 (2) Neulasta
Amgen Inc.
1.55% Stats
71 (2) Orencia
Bristol-Myers Squibb Company
-4.39% Stats
72 (1) Sensipar
Amgen Inc.
-4.08% Stats
73 (2) Lunesta
Sunovion Pharmaceuticals Inc.
-6.17% Stats
74 Xolair
n/a Stats
75 (1) Procrit
Janssen Pharmaceuticals, Inc.
2.47% Stats
76 () Gardasil
Merck
n/a Stats
77 (2) Adderall XR
Takeda Pharmaceutical Company Limited
-6.73% Stats
78 (1) Lucentis
Genentech, Inc.
2.62% Stats
79 (2) Isentress
Merck
-3.30% Stats
80 (2) Prezista
Janssen Pharmaceuticals, Inc.
-3.37% Stats
81 Aranesp
Amgen Inc.
1.66% Stats
82 (2) Reyataz
Bristol-Myers Squibb Company
-9.20% Stats
83 (1) Copaxone
Teva Pharmaceuticals USA, Inc.
-6.58% Stats
84 (1) Alimta
Eli Lilly and Company
-5.50% Stats
85 (1) Prevnar 13
Pfizer Inc.
3.05% Stats
86 (2) Herceptin
Genentech, Inc.
-2.41% Stats
87 (2) Neupogen
Amgen Inc.
-4.88% Stats
88 (1) Invega Sustenna
Janssen Pharmaceuticals, Inc.
n/a Stats
89 () Zostavax
Merck
n/a Stats
90 (1) Xgeva
Amgen Inc.
2.36% Stats
91 (1) Betaseron
Bayer HealthCare Pharmaceuticals Inc.
37.93% Stats
92 () Tecfidera
Biogen
n/a Stats
93 (2) Gleevec
Novartis Pharmaceuticals Corporation
-11.36% Stats
94 (4) Avonex
Biogen
-14.77% Stats
95 Gilenya
Novartis Pharmaceuticals Corporation
-1.61% Stats
96 (2) Xeloda
Genentech, Inc.
-6.35% Stats
97 (1) Avonex Pen
Biogen
-7.69% Stats
98 (1) Zytiga
Janssen Pharmaceuticals, Inc.
n/a Stats
99 (1) Stelara
Janssen Pharmaceuticals, Inc.
3.85% Stats
100 (1) Afinitor
Novartis Pharmaceuticals Corporation
n/a Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.